Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

Details Indazole, benzisoxazole, and benzisothiazole kinase inhibitors Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

2007-11-20

2007-11-20

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S362100

Reexamination Certificate

active

10842292

ABSTRACT:
Compounds having the formulaare useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 5773459 (1998-06-01), Tang et al.
patent: 6177401 (2001-01-01), Ullrich et al.
patent: 6262040 (2001-07-01), Marfat
patent: 136745 (1984-08-01), None
patent: 816382 (1959-07-01), None
patent: 1995021613 (1995-08-01), None
patent: 1996023783 (1996-08-01), None
patent: 1996040637 (1996-12-01), None
patent: 1997037989 (1997-10-01), None
patent: 97/42187 (1997-11-01), None
patent: 1999000357 (1999-01-01), None
patent: 1999032463 (1999-07-01), None
patent: 00/27627 (2000-05-01), None
patent: 2000042012 (2000-06-01), None
patent: 01/19828 (2001-03-01), None
patent: 2001019788 (2001-03-01), None
patent: 2002014311 (2002-02-01), None
patent: 02/055517 (2002-07-01), None
patent: 2002062763 (2002-08-01), None
patent: 2002070494 (2002-09-01), None
patent: 03/051847 (2003-06-01), None
patent: 2003068228 (2003-08-01), None
patent: 03/087072 (2003-10-01), None
patent: 03/097610 (2003-11-01), None
patent: 2004/010995 (2004-02-01), None
patent: 2004/022544 (2004-03-01), None
patent: 2004/062662 (2004-07-01), None
Cullinan-Bove et al., “Vascular endothelial growth factor/vascular permeability factor expression I the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth,” Endocrinology 133(2):829-837 (1993).
Derbyshire et al., “Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids,” Int. J. Cancer 63(5):694-701 (1995).
Mongin et al., “Regioselective ortho-lithiation of chloro and bromo substituted fluoroarenes,” Tetrahedron Letters 37(36):6551-6554 (1996).
Passaniti et al., “Methods in laboratory investigation,” Laboratory Investigation 67(4):519-528 (1992).
Rupert et al., “Suzuki couplings with phthalimidines-an efficient route to staurosporinone analogs,” Heterocycles 45(11):2217-2221 (1997).
Silvagno et al., “In vivo activation ofmettyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis,” Vasc. Biol. 15(11):1857-1856 (1995).
Songyang et al., “Catalytic specificity of protein-tyrosine kinases is critical for selective signalling,” Nature 373:536-539 (1995).
Thistlethwaite et al., “Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy,” J. Thorac. Cardiovasc. Surg. 122(1):65-73 (2001).
Wilson et al., “Human prostate tumor angiogenesis in nude mice: metalloprtoease and plasminogen activator activities during tumor growth and neovasularization of subcutaneously injected matrigel impregnated with human prostate tumor cells,” Anat. Rec. 249(1):63-73 (1997).

Affiliated with

Also associated with

Rating

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazole, benzisoxazole, and benzisothiazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole, benzisoxazole, and benzisothiazole kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3843267